Table 1 shows the results of a study comparing immune responses in mice vaccinated by different routes:
Vaccination Route | Serum IgG Level (mg/dL) | Mucosal IgA Level (mg/dL) | Cellular Immunity (CD8+ T cells per mL)
Intramuscular | 420 | 8 | 95,000
Subcutaneous | 385 | 6 | 88,000
Oral | 95 | 140 | 62,000
Intranasal | 180 | 185 | 74,000
Note: IgG provides systemic protection; IgA protects mucosal surfaces (respiratory, gut); CD8+ T cells kill infected cells.
For a vaccine targeting a respiratory virus (which enters through nasal mucosa), which route would produce the most relevant immune response?
- AIntranasal, because it produces the highest mucosal IgA (185 mg/dL), which protects respiratory surfaces.Correct
- BIntramuscular, because it produces the highest IgG levels.
- COral, because it produces much higher mucosal IgA (140 mg/dL) than either intramuscular or subcutaneous injection.
- DSubcutaneous, because it is close to the respiratory system.
Why A is right
Respiratory viruses enter through the nasal mucosa and are primarily blocked by mucosal IgA at the infection site. Intranasal vaccination produces the highest IgA (185 mg/dL) — the antibody most relevant to preventing respiratory virus entry — while also providing substantial systemic IgG and cellular immunity.
Why the other 3 choices miss
- B
- Incorrect because while intramuscular produces the most IgG, systemic IgG is less effective at blocking respiratory virus entry than mucosal IgA, which is directly present at the nasal surface.
- C
- Incorrect because while oral vaccination does produce more mucosal IgA (140 mg/dL) than either injection route, it is lower than intranasal (185 mg/dL), and oral IgA is more relevant to gut protection than respiratory.
- D
- Incorrect because subcutaneous injection is not anatomically close to the respiratory system in a biologically meaningful way, and it produces the second-lowest mucosal IgA (6 mg/dL).
An immunologist studied the antibody response to three vaccines administered at different time points. Subjects received a primary vaccination (Week 0) and booster vaccinations (Week 4 and Week 16). Serum antibody titers (log₁₀ units): Week 0: Vaccine A = 0.3, B = 0.2, C = 0.4. Week 2: A = 1.8, B = 0.9, C = 2.1. Week 4: A = 3.2, B = 2.4, C = 3.8. Week 6 (post-booster 1): A = 4.8, B = 4.1, C = 5.2. Week 10: A = 4.1, B = 3.6, C = 4.6. Week 16: A = 3.5, B = 3.1, C = 4.0. Week 18 (post-booster 2): A = 5.6, B = 5.0, C = 6.3. Which vaccine produces the highest antibody titer at all time points?
- AVaccine CCorrect
- BVaccine B
- CVaccines A and C show identical titers throughout.
- DVaccine A
Why A is right
Comparing values at each time point, Vaccine C consistently has the highest titer: Week 2: C = 2.1 > A = 1.8 > B = 0.9. Week 4: C = 3.8 > A = 3.2 > B = 2.4. Week 6: C = 5.2 > A = 4.8 > B = 4.1. Week 10: C = 4.6 > A = 4.1 > B = 3.6. Week 16: C = 4.0 > A = 3.5 > B = 3.1. Week 18: C = 6.3 > A = 5.6 > B = 5.0. Vaccine C produces the highest titers at all measured time points.
Why the other 3 choices miss
- B
- Incorrect because Vaccine B consistently produces the lowest antibody titers at all time points.
- C
- Incorrect because Vaccines A and C have different titers at every time point; C is consistently higher than A.
- D
- Incorrect because Vaccine A produces lower titers than Vaccine C at every time point, though higher than Vaccine B.
An immunologist studied the production of antibodies (IgG, mg/mL) following vaccination in three age groups: children (8–12 yr), young adults (25–35 yr), and elderly (70–80 yr). Three vaccine types were tested. Antibody concentration at 4 weeks post-vaccination: Vaccine type / Children / Young adults / Elderly: mRNA vaccine: 58.4 / 72.1 / 31.2. Protein subunit vaccine: 44.2 / 55.8 / 28.7. Live attenuated vaccine: 71.8 / 68.3 / 22.4. Which age group shows the weakest antibody response across all three vaccine types?
- AYoung adults
- BChildren
- CChildren and elderly show equally weak responses.
- DElderlyCorrect
Why D is right
Antibody concentrations for the elderly: mRNA = 31.2, protein subunit = 28.7, live attenuated = 22.4 mg/mL. Comparing across age groups: children have values of 58.4, 44.2, 71.8; young adults have 72.1, 55.8, 68.3. The elderly consistently have the lowest antibody responses for all three vaccine types. This reflects immunosenescence — age-related decline in immune function.
Why the other 3 choices miss
- A
- Incorrect because young adults have the highest or near-highest antibody responses for all vaccines (55.8–72.1 mg/mL).
- B
- Incorrect because children show substantial antibody responses (44.2–71.8 mg/mL), similar to or exceeding young adults for some vaccines.
- C
- Incorrect because children's responses (44.2–71.8 mg/mL) are substantially higher than elderly responses (22.4–31.2 mg/mL); they are not equally weak.